4.8 Article

IMGT (R), the international ImMunoGeneTics information system (R)

Journal

NUCLEIC ACIDS RESEARCH
Volume 37, Issue -, Pages D1006-D1012

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/nar/gkn838

Keywords

-

Funding

  1. BIOMED1 [BIOCT930038]
  2. Biotechnology BIO-TECH2 [BIO4CT960037]
  3. European Union (EU) [QLG2-2000-01287]
  4. CNRS
  5. Ministere de l'Enseignement Superieur et de la Recherche (MESR) (Universite Montpellier 2 Plan Pluri-Formation, Institut Universitaire de France)
  6. Reseau National des Genopoles
  7. Region Languedoc-Roussillon
  8. Agence Nationale de la recherche ANR [BIOSYS06_135457, FLAVORES]
  9. EU Immuno-Grid [IST-028069]

Ask authors/readers for more resources

IMGT (R), the international ImMunoGeneTics information system (R) (http://www.imgt.org), was created in 1989 by Marie-Paule Lefranc, Laboratoire d'ImmunoGenetique Moleculaire LIGM (Universite Montpellier 2 and CNRS) at Montpellier, France, in order to standardize and manage the complexity of immunogenetics data. The building of a unique ontology, IMGT-ONTOLOGY, has made IMGT (R) the global reference in immunogenetics and immunoinformatics. IMGT (R) is a high-quality integrated knowledge resource specialized in the immunoglobulins or antibodies, T cell receptors, major histocompatibility complex, of human and other vertebrate species, proteins of the IgSF and MhcSF, and related proteins of the immune systems of any species. IMGT (R) provides a common access to standardized data from genome, proteome, genetics and 3D structures. IMGT (R) consists of five databases (IMGT/LIGM-DB, IMGT/GENE-DB, IMGT/3Dstructure-DB, etc.), fifteen interactive online tools for sequence, genome and 3D structure analysis, and more than 10 000 HTML pages of synthesis and knowledge. IMGT (R) is used in medical research (autoimmune diseases, infectious diseases, AIDS, leukemias, lymphomas and myelomas), veterinary research, biotechnology related to antibody engineering (phage displays, combinatorial libraries, chimeric, humanized and human antibodies), diagnostics (clonalities, detection and follow-up of residual diseases) and therapeutical approaches (graft, immunotherapy, vaccinology). IMGT is freely available at http://www.imgt.org.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available